425: Strive, Semler Scientific Announce Merger Plans

Strive, Inc. and Semler Scientific, Inc. announced a proposed business combination, with Strive filing a Form 425 related to the merger.

Summary

• Strive, Inc. and Semler Scientific, Inc. are pursuing a proposed business combination.
• This communication was posted on X.com by Strive's Chief Risk Officer, CEO, and CFO on September 22, 2025.
• The filing serves as a cautionary statement regarding forward-looking statements related to the proposed transaction.
• It outlines various risks and uncertainties that could cause actual results to differ materially from anticipated outcomes.
• Information on where to find additional details about the proposed transaction, including SEC filings, is provided.

Sentiment

Score: 6

Explanation: The filing announces a proposed merger, which is generally a positive strategic development. However, it is primarily a cautionary statement detailing numerous risks and uncertainties, tempering the overall sentiment to neutral-to-slightly-positive.

Positives

• The proposed transaction is expected to yield strategic and financial benefits for the combined company.
• The merger aims to impact the combined company's future financial performance positively.

Risks

• The occurrence of any event, change, or circumstances that could lead to the termination of the merger agreement.
• The proposed transaction may not close as expected or at all if closing conditions are not satisfied on a timely basis.
• Potential legal proceedings against Strive, Semler Scientific, or the combined company.
• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected or at all.
• Risks associated with Bitcoin and other digital assets, general economic and market conditions, interest and exchange rates, monetary policy, and regulatory enforcement could impact benefits.
• Integration of the two companies may be more difficult, time-consuming, or costly than anticipated.
• The proposed transaction may be more expensive or take longer to complete than expected due to unforeseen factors.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the transaction.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before the closing of the transaction.
• Other unknown or unpredictable factors could harm the results of Strive, Semler Scientific, or the combined company.

Future Outlook

Expectations for the proposed transaction include strategic and financial benefits, a positive impact on the combined company's future financial performance, and successful integration. However, these are forward-looking statements subject to significant risks and uncertainties, and actual results may differ materially.

Management Comments

• Strive, Inc. (Strive), Jeff Walton, Chief Risk Officer, Matthew Cole, Chief Executive Officer, and Ben Pham, Chief Financial Officer of Strive posted the communication on X.com regarding the proposed business combination with Semler Scientific, Inc.

Industry Context

The proposed business combination reflects a strategic move common in various industries for growth and synergy. The mention of 'Bitcoin treasury strategies' for the combined entity indicates an engagement with emerging digital asset trends, which is a notable development in corporate finance and investment strategies.

Stakeholder Impact

• Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock.
• Semler Scientific stockholders will need to approve the proposed transaction.
• Customers of both companies may have adverse reactions or changes to business relationships.
• Employee relationships at both companies could be affected by the announcement or completion of the proposed transaction.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register Class A common stock to be issued in connection with the proposed transaction.
• The Registration Statement will include an Information Statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available, along with other relevant SEC documents.

Key Dates

Recommendation

The filing announces a proposed business combination between Strive and Semler Scientific, a significant strategic event. However, it is primarily a cautionary statement detailing numerous risks and uncertainties associated with the merger, including integration challenges, potential non-realization of benefits, and dilution. Without specific financial terms or updated projections, a 'hold' recommendation is prudent, awaiting further detailed disclosures in the Form S-4 and proxy statement to assess the full financial implications and synergy potential.

Keywords

Merger, Acquisition, Business Combination, Strive Inc., Semler Scientific Inc., SEC Filing, Form 425, Forward-Looking Statements, Corporate Governance, Bitcoin Treasury